logo
Select company
Select metric
3.57Cash Ratio
VS
Market
90
Sector
80
Industry
71
History
48
$ 6.49Close
$ 2 - $ 6.78 52-Week Range
Ticker Information

Ticker

RLAY

Company Name

RELAY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RELAY THERAPEUTICS INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLAY - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 116.2M3.57$ 32.52M
3/31/2025$ 95.66M2.58$ 37.05M
12/31/2024$ 126.41M2.49$ 50.73M
9/30/2024$ 154.48M3.29$ 46.97M
6/30/2024$ 136.83M3.04$ 45.04M
3/31/2024$ 155.57M4.19$ 37.14M
12/31/2023$ 146.44M4.84$ 30.27M
9/30/2023$ 154.03M3.04$ 50.75M
6/30/2023$ 148.61M2.08$ 71.58M
3/31/2023$ 163.85M2.33$ 70.47M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) Cash Ratio stands at 35.76.
  • Over the past 5 years, RELAY THERAPEUTICS INC's average Cash Ratio has been 7.97.
  • The median Cash Ratio for RELAY THERAPEUTICS INC during this period was 3.43
  • RELAY THERAPEUTICS INC reached its highest Cash Ratio over the past 5 years at 35.76.
  • The lowest Cash Ratio recorded by RELAY THERAPEUTICS INC in the same timeframe 2.08

RELAY THERAPEUTICS INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
TSHA : TAYSHA GENE THERAPIES INC 12.44DNTH : DIANTHUS THERAPEUTICS INC 0.66TNXP : TONIX PHARMACEUTICALS HOLDING CORP 6.58PRME : PRIME MEDICINE INC 1.98PGEN : PRECIGEN INC 0.59PRTA : PROTHENA CORP PUBLIC LTD CO 5.48ABSI : ABSCI CORP 1.73FATE : FATE THERAPEUTICS INC 1.8TVRD : TVARDI THERAPEUTICS INC 1.93PRAX : PRAXIS PRECISION MEDICINES INC 3.24

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for RELAY THERAPEUTICS INC is calculated as follows: CashnEq [ $ 560.16M ] / LiabilitesC [ $ 15.67M ]
(=) Cash Ratio [ 35.76 ]

RLAY - Cash Ratio, Last 5 years

2.08

Minimum

Jun 30, 2023

35.76

Maximum

Sep 30, 2020

7.97

Average

3.43

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63